Take care with p53
The protein p53—so called because it is a phosphoprotein with a molecular mass of 53 kD—could be one of the most important molecules in biology, writes an expert in cancer genetics (p 2539). p53 helps control angiogenesis, apoptosis, and cell cycling, DNA repair, and regulation of oxidative stress, all of which are key processes in the growth and development of cancers. Abnormalities in TP53—the gene that encodes p53—are common in many cancers and are often associated with prognosis. In one recent study, disruptive mutations of TP53 within squamous cell cancers of the head and neck were associated with significantly shorter survival (hazard ratio for death 1.7, 95% CI 1.2 to 2.4)⇑.
Exploiting what we already know about this protein and its gene won’t be easy. The functions of p53 are so diverse that manipulating them—with gene therapy, for example—could have widespread and unpredictable effects. Overexpression of TP53 causes premature ageing in mice, while at least one polymorphism is associated with longer life in humans, despite a small increase in the risk of cancer. p53 seems to be “master and commander” of the cellular processes that control growth, life, and death. We should be careful what we do with it.
One vertebral fracture leads to another, for at least 15 years
Once a woman reaches 65, her absolute risk of a vertebral fracture depends firstly on whether or not she already has one and secondly on her bone mineral density (BMD). In the longest cohort study so far, women with a previous fracture and established osteoporosis had a greater than 50% chance of a new vertebral fracture over the next 15 years, compared with less than 10% for women with neither. The two risk factors operated independently of each other⇑.
History of fracture was a better …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012